SeLux Diagnostics, Inc.

Precision diagnostics for infectious diseases - Selux Diagnostics

Charlestown, United States · Founded 2016 · $151.4M raised

Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$151.4M
Last Round
$48.0M Series DMar 2024
Rounds
10

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Selux Diagnostics is a Boston-based company developing precision diagnostics for infectious diseases and combating antimicrobial resistance. Its proprietary Next Generation Phenotyping (NGP) System delivers rapid, high-throughput antimicrobial susceptibility testing (AST) and minimum inhibitory concentration (MIC) results for clinical microbiology labs. By closing the gap between infection identification and susceptibility testing, Selux enables personalized treatment decisions that help halt the spread of antibiotic-resistant superbugs and preserve the efficacy of antibiotics. The company has received FDA Breakthrough Device Designation, FDA clearance for its NGP System, and BARDA funding in recognition of its potential to transform infectious disease treatment.

Summary

SeLux Diagnostics, Inc. is a Diagnostics company based in Charlestown, United States, founded in 2016. It has raised $151.4M in total across 10 rounds, most recently a $48.0M Series D round in Mar 2024. Investors include Biomedical Advanced Research and Development Authority (BARDA), RA Capital Management and Christopher Herr.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DMar 2024
$48.0M

Sign up to see all 11 events

Funding: Grant through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SeLux Diagnostics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/selux-diagnostics-inc"><img src="https://indexed.vc/api/badge/company/selux-diagnostics-inc" alt="SeLux Diagnostics, Inc. on Indexed.vc" width="260" height="76" /></a>